High HDAC-6 expression was more frequently observed in pancreatic adenocarcinoma patients with smaller tumor size and absence of organ metastases, at a non significant level though (Table 4, p = 0.0864 and p = 0.0663, respectively). This evidence concerns the gene HDAC6 and pancreatic adenocarcinoma.